Account for EUBIJ content access
Login / Register
Login / Register
Targets:
Autoimmune disease, Renal disease, Pain and Neurodegenerative disease, Bone disease or Platform Technologies for Drug Discovery
GRANT
Up to US$200,000 funding per year for each selected proposal, up to 3 years depending on the research content.
Eligible Candidates:
Researchers from a university or research institute outside Japan (academia, pharmaceutical company, biotech, start-up, etc.).
Students are not accepted.
Application Period: between January 5, 2023, and February 28, 2023.
Find more detailed info from the website below.
https://www.asahikasei-pharma.co.jp/a-compass/en/recruit.html
===================
Interested in being kept informed of other supports from the EU-Japan Centre?
Feel free to fill in the form at https://www.eu-japan.eu/be-informed
We look forward to receiving your application!
The EU-Japan Centre currently produces 5 newsletters :
Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.
The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026
